Company
More than 35 Years of Excellence in Medical Devices
Accura Medizintechnik GmbH supplies high quality medical products on a global level. Our core products are stents (balloon-expandable and self-expandable), balloons for coronary and peripheral application, catheters and a broad range of accessories for interventional Cardiology and Radiology. Additionally, we supply components for the medical industry, e.g. special tubes and adhesive tapes. Moreover, Accura offers a product search service which includes the sourcing of niche products.
As a medium sized company, Accura develops customer value from its lean organizational structure. This results in quick response time, satisfaction of individual customer needs and less cost efforts. Consequently, Accura supplies German quality products for highly competitive prices.
Our aim is to further extend long lasting relationships with our key customers and to increase sustainable partnerships.
History
|
1983 |
Foundation of Accura Medizintechnik GmbH by Martin Bruch in Maintal / Frankfurt (Germany). Focus was to sell catheters for vascular surgery in the domestic market. |
|
1985 |
Cooperation to produce infusion accessories |
|
1987 |
Growth strategy: Accura defined interventional cardiology and radiology products as core products and started to sell on an international level |
|
1989 |
Establishing own offices and warehouse in Karben / Frankfurt (Germany) |
|
1996 |
Implementation of ISO 9001 and later DIN EN ISO 13485 |
|
2006 |
Expansion of the facilities in Karben / Frankfurt (Germany) |
|
2009 |
Invitation to accompany the Vice Minister of Economics & Technology of the Federal Republic of Germany during his trip to East Asia |
|
2010 |
Invitation to accompany the Minister of Economics of the Federal Republic of Germany during his business trip to China and Japan |
|
2012 |
Extension of the product range by adding special products such as the Aspiration Catheter UNBLOCKER |
|
2013 |
Starting a broad product line of PTA Catheters in many dimensions for different applications |
|
2014 |
CE Certification for Sirolimus Drug Eluting Stent Decent S |
|
2018 |
Start of marketing the heart support device IVAC2L |
|
2021 |
Distribution of Bioresobable Stents to selected countries |
